Target Name: DUSP5P1
NCBI ID: G574029
Review Report on DUSP5P1 Target / Biomarker Content of Review Report on DUSP5P1 Target / Biomarker
DUSP5P1
Other Name(s): DUSP5P | RP4-621O15.2 | dual specificity phosphatase 5 pseudogene 1 | Dual specificity phosphatase 5 pseudogene 1

DUSP5P1: A Promising Drug Target and Biomarker

DUSP5P1, also known as DUSP5P, is a protein that is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. Its full name is domains unique among structurally similar proteins, which suggests that it has unique functions in the cell.

One of the most interesting aspects of DUSP5P1 is its potential as a drug target. The protein is known to interact with several different drug molecules, including small molecules, peptides, and proteins. This suggests that DUSP5P1 could be a useful biomarker or drug target in various diseases.

DUSP5P1 has been shown to play a role in several different diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that DUSP5P1 is overexpressed in various types of cancer, including breast, ovarian, and colorectal cancer. This suggests that targeting DUSP5P1 could be a promising strategy for treating these diseases.

In addition to its potential as a drug target, DUSP5P1 has also been shown to be a useful biomarker in several diseases. For example, studies have shown that DUSP5P1 is overexpressed in individuals with type 2 diabetes, which suggests that targeting DUSP5P1 could be a promising strategy for treating this disease.

DUSP5P1 has also been shown to interact with several different small molecules, including drugs that are currently being used to treat various diseases. For example, studies have shown that DUSP5P1 is inhibited by the small molecule drugletok, which is used to treat attention deficit hyperactivity disorder (ADHD). This suggests that targeting DUSP5P1 with drugs that are currently being used to treat ADHD could be a promising strategy for treating this disease.

In addition to its potential as a drug target and biomarker, DUSP5P1 has also been shown to play a role in several different biological processes in the cell. For example, studies have shown that DUSP5P1 is involved in the regulation of cell adhesion, which is the process by which cells stick together and form tissues. This suggests that DUSP5P1 could be a useful target for drugs that are currently being used to treat various diseases.

Overall, DUSP5P1 is a protein that has shown promise as a drug target and biomarker in a variety of diseases. Its unique structure and various functions in the cell make it an attractive target for researchers to study and develop new treatments. Further research is needed to fully understand the role of DUSP5P1 in the treatment of various diseases.

Protein Name: Dual Specificity Phosphatase 5 Pseudogene 1

The "DUSP5P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DUSP5P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

DUSP6 | DUSP7 | DUSP8 | DUSP8P5 | DUSP9 | DUT | DUTP6 | DUX1 | DUX3 | DUX4 | DUX4L1 | DUX4L13 | DUX4L16 | DUX4L18 | DUX4L19 | DUX4L2 | DUX4L20 | DUX4L23 | DUX4L3 | DUX4L37 | DUX4L4 | DUX4L5 | DUX4L6 | DUX4L7 | DUX4L8 | DUX4L9 | DUXA | DUXAP10 | DUXAP3 | DUXAP8 | DUXAP9 | DVL1 | DVL2 | DVL3 | DXO | DYDC1 | DYDC2 | DYM | Dynactin | DYNAP | DYNC1H1 | DYNC1I1 | DYNC1I2 | DYNC1LI1 | DYNC1LI2 | DYNC2H1 | DYNC2I1 | DYNC2I2 | DYNC2LI1 | DYNLL1 | DYNLL2 | DYNLRB1 | DYNLRB2 | DYNLRB2-AS1 | DYNLT1 | DYNLT2 | DYNLT2B | DYNLT3 | DYNLT4 | DYNLT5 | DYRK1A | DYRK1B | DYRK2 | DYRK3 | DYRK4 | DYSF | Dystrophin-Associated Glycoprotein Complex | DYTN | DZANK1 | DZIP1 | DZIP1L | DZIP3 | E2F Transcription Factor | E2F-6 complex | E2F1 | E2F2 | E2F3 | E2F4 | E2F5 | E2F6 | E2F6P4 | E2F7 | E2F8 | E3 ubiquitin-protein ligase | E4F1 | EAF1 | EAF2 | EAPP | Early growth response | EARS2 | EBAG9 | EBF1 | EBF2 | EBF3 | EBF4 | EBI3 | EBLN1 | EBLN2 | EBLN3P | EBNA1BP2